Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor-Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04049669
What this trial is testing

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Who this might be right for
GlioblastomaMedulloblastomaEpendymoma+1 more
Theodore S. Johnson 130
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)WithdrawnNCT06501911
What this trial is testing

Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

Who this might be right for
Recurrent GlioblastomaRecurrent High-grade Glioma
University of Nebraska
Early research (Phase 1)Ended earlyNCT03971734
What this trial is testing

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Who this might be right for
High Grade GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Early research (Phase 1)Ended earlyNCT00089245
What this trial is testing

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
Y-mAbs Therapeutics 177
Testing effectiveness (Phase 2)Study completedNCT00027612
What this trial is testing

Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 58
Not applicableStudy completedNCT01346267
What this trial is testing

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Central Nervous System Tumor, PediatricChemotherapy-induced Nausea and VomitingUnspecified Childhood Solid Tumor, Protocol Specific
University of South Florida 187
Not applicableUnknownNCT00418899
What this trial is testing

Gliogene: Brain Tumor Linkage Study

Who this might be right for
Brain TumorGlioma
M.D. Anderson Cancer Center 17,080
Not applicableUnknownNCT04174820
What this trial is testing

Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition

Who this might be right for
Medulloblastoma, ChildhoodHealthy VolunteersFossa Posterior Tumor+1 more
University Hospital, Angers 145
Testing effectiveness (Phase 2)Study completedNCT01756989
What this trial is testing

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Who this might be right for
Brainstem Glioma
Helsinki University Central Hospital 50
Early research (Phase 1)Active Not RecruitingNCT03535350
What this trial is testing

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Case Comprehensive Cancer Center 36
Not applicableLooking for participantsNCT06989086
What this trial is testing

FearLess in NeuroOncology

Who this might be right for
Primary Malignant Brain TumorGlioblastoma (GBM)Astrocytoma+2 more
Virginia Commonwealth University 112
Testing effectiveness (Phase 2)Study completedNCT02717962
What this trial is testing

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 118
Large-scale testing (Phase 3)Study completedNCT00749723
What this trial is testing

Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children

Who this might be right for
Recurrent Brain TumorsSupratentorial PNETsMedulloblastomas+1 more
University Hospital, Bonn 174
Large-scale testing (Phase 3)UnknownNCT00278278
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
German Society for Pediatric Oncology and Hematology GPOH gGmbH 150
Testing effectiveness (Phase 2)Study completedNCT01740258
What this trial is testing

Bevacizumab Beyond Progression (BBP)

Who this might be right for
Malignant GliomaGrade 4 Malignant GliomaGlioblastoma+1 more
Duke University 68
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Not applicableUnknownNCT02652897
What this trial is testing

Hemostasis Alterations in Neurosurgical Patients

Who this might be right for
GliomaCoagulopathyAcquired Platelet Function Disorder+2 more
Santiago R. Leal-Noval 120
Testing effectiveness (Phase 2)Study completedNCT00427440
What this trial is testing

A Phase II Study to Treat Advanced Malignant Glioma

Who this might be right for
Advanced Malignant Glioma
Amgen 61
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Next Page